The natural course of cutaneous melanoma

被引:183
作者
Leiter, U [1 ]
Meier, F [1 ]
Schittek, B [1 ]
Garbe, C [1 ]
机构
[1] Univ Tubingen, Dept Dermatol, Div Dermatol Oncol, D-72076 Tubingen, Germany
关键词
cutaneous melanoma; metastatic pathways; pathogenesis; metastatic pattern; sentinel lymph node biopsy;
D O I
10.1002/jso.20079
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The natural course of cutaneous melanoma (CM) is determined by its metastatic spread and depends on tumor thickness, ulceration, gender, localization, and the histologic subtype of the primary tumor. CM metastasis develops via three main metastatic pathways and occurs as satellite or in-transit metastasis, as regional lymph node metastasis or as distant metastasis at the time of primary recurrence. About 50% of all CM patients with tumor progression firstly develop regional lymph node metastases. In the other 50% the first metastases are satellite or in-transit metastases (about 20%), or immediately distant metastases (about 30%). Development of distant metastasis appears to be an early event in metastatic spread and may in the majority of cases originate from the primary tumor, only few cases may develop secondarily to locoregional metastasis. Reporting of organ involvement in distant metastasis greatly differs between the results of imaging techniques and autopsy results in respect to the metastatic patterns detected, pointing out that there is a need of improved imaging systems. Proliferation, neovascularization, lymphangiogenesis, invasion, circulation, and embolism are important steps in the pathogenesis of CM metastasis, with tumor vascularity as an important independent significant prognostic factor. The expression of chemokine receptors in cancer cells associated with the expression of the respective chemokine receptor ligands in the target sites of the metastasis is an interesting observation which may stimulate the development of new therapeutic strategies. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:172 / 178
页数:7
相关论文
共 75 条
[1]  
ALCALA JAC, 2001, ARCH ESP UROL, V54, P685
[2]   The surgical management of metastatic melanoma [J].
Allen, PJ ;
Coit, DG .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (08) :762-770
[3]   MULTIFACTORIAL ANALYSIS OF MELANOMA - PROGNOSTIC HISTOPATHOLOGICAL FEATURES COMPARING CLARKS AND BRESLOWS STAGING METHODS [J].
BALCH, CM ;
MURAD, TM ;
SOONG, SJ ;
INGALLS, AL ;
HALPERN, NB ;
MADDOX, WA .
ANNALS OF SURGERY, 1978, 188 (06) :732-742
[4]   A MULTIFACTORIAL ANALYSIS OF MELANOMA .4. PROGNOSTIC FACTORS IN 200 MELANOMA PATIENTS WITH DISTANT METASTASES (STAGE III) [J].
BALCH, CM ;
SOONG, SJ ;
MURAD, TM ;
SMITH, JW ;
MADDOX, WA ;
DURANT, JR .
JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (02) :126-134
[5]   CUTANEOUS MELANOMA - PROGNOSIS AND TREATMENT RESULTS WORLDWIDE [J].
BALCH, CM .
SEMINARS IN SURGICAL ONCOLOGY, 1992, 8 (06) :400-414
[6]   Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [J].
Balch, CM ;
Soong, SJ ;
Gershenwald, JE ;
Thompson, JF ;
Reintgen, DS ;
Cascinelli, N ;
Urist, M ;
McMasters, KM ;
Ross, MI ;
Kirkwood, JM ;
Atkins, MB ;
Thompson, JA ;
Coit, DG ;
Byrd, D ;
Desmond, R ;
Zhang, YT ;
Liu, PY ;
Lyman, GH ;
Morabito, A .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3622-3634
[7]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[8]  
BARTH A, 1995, CANCER, V75, P726, DOI 10.1002/1097-0142(19950115)75:2+<726::AID-CNCR2820751417>3.0.CO
[9]  
2-R
[10]  
BARTH A, 1995, J AM COLL SURGEONS, V181, pA193